Sophiris Bio Inc.
Pharmaceutical ManufacturingCalifornia, United States2-10 Employees
Sophiris Bio Inc. (NASDAQ: SPHS), a biopharmaceutical company developing topsalysin (PRX302) for the treatment of urological diseases
Sophiris Bio Inc. uses 8 technology products and services including Drupal, WordPress, MySQL, and more. Explore Sophiris Bio Inc.'s tech stack below.
| Sophiris Bio Inc. Email Formats | Percentage |
| FLast@sophirisbio.com | 39% |
| First@sophirisbio.com | 11% |
| FLast@sophirisbio.com | 39% |
| First@sophirisbio.com | 11% |
Pharmaceutical ManufacturingCalifornia, United States2-10 Employees
Sophiris Bio Inc. (NASDAQ: SPHS), a biopharmaceutical company developing topsalysin (PRX302) for the treatment of urological diseases
Sophiris Bio Inc. has raised a total of $10M of funding over 5 rounds. Their latest funding round was raised on Sep 14, 2017 in the amount of $10M.
Sophiris Bio Inc.'s revenue is estimated to be in the range of $1M
Sophiris Bio Inc. has raised a total of $10M of funding over 5 rounds. Their latest funding round was raised on Sep 14, 2017 in the amount of $10M.
Sophiris Bio Inc.'s revenue is estimated to be in the range of $1M